Buruli溃疡病研究进展

摘要/Abstract

摘要： Buruli溃疡病 (Buruliulcerdisease ,BUD) ,又称Bairnsdale溃疡病 ,是由溃疡分枝杆菌 (Mycobacteriumulcerans)感染的一种慢性溃疡性皮肤病。Cook于1897年在乌干达首次发现本病^[1] 。1962年乌干达Buruli地区不少儿童皮肤罹患本病 ,因此将其命名为BUD。近 10年来全球BUD发病率不断上升。在免疫正常的人群中已成为继结核和麻风之后第三种最常见的分枝杆菌性疾病 ,其发病率位居结核分枝杆菌之首。 1998年世界卫生组织 (WHO)召开国际会议 ,动员全球学者努力认识和攻克该病^[2]。

李妍,张建中,. Buruli溃疡病研究进展[J]. 中国防痨杂志, 2004, 26(5): 298-300.

参考文献

1 Van der Werf T S,Van der Graaf W T，Tapper.J W，et ai. Myco-bacterium ulcerans infection [J].Lancet, 1999,354(9183):1013～1018.
2 Weir E. Buruli ulcer: the third most common mycobacterial infec-tion [J].CMAJ,2002,166(13):1691.
3 Portaels F, Chemlal K，Elsen P,et al.Mycobacterium ulcerans in wild animals [jj.Rev Sci Tec,2001,20(1):252～264.
4 Debacker M,Zinsou C, Aguiar J,et al. First case of Mycobacterium ulcerans disease (Buruli ulcer) following a human bite [J]. Clin In-fect Dis，2003,36(5):67～68.
5 Hofer M, Hirschel B, Kirschner P, et al. Brief report: disseminated osteomyelitis from Mycobacterium ulcerans after a snakebite [J].N EnglJ Med,1993,328(14):1007～1009.
6 Stienstra Y, van der Graaf W T，te Meerman GJ,et al.Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors [J].Trop Med Int Health,2001,6(7):554-562.
7 Jenkin G A, Smith M, Fairley M，et al. Acute, oedematous Myco-bacterium ulcerans infection in a farmer from far north Queensland[J].Med J Aust，2002,176(4):180～181.
8 Lagarrigue V，Portaels F, Meyers W M,et al.Buruli ulcer：risk ofbone involvement！ Apropos of 33 cases observed in Benin [J].Med Trop (Mars),2000,60(3):262～266.
9 Guarner J, Bartlett J, Whitney E A,et al. Histopathologic geatures of Mycobacterium ulceransinfection [J].Emerg Infect Dis,2003，9(6):651～656.
10 Delaporte E，Savage C, Alfandari S,et al. Buruli ulcer in a Zairian woman with HIV infection [J].Ann Dermatol Venereol，1994,121(8):557～560.
11N’Guessan K, Kouassi Y, Bouzid S, et al. Value and limits of microscopy of exudates in Mycobacterium ulcerans cutaneous infection in Cote d'I voire [J].Bull Soc Pathol Exot,2001,94(1):9～10.
12 Portales F, Aguiar J, Fissette K,et al. Direct detection and identifi-cation of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization [J].J Clin Microbiol, 1997,35(5):1097～1100.
13 Stinear T,Davies J K,Jenkin G A,et al.A simple PCR method for rapid genotype analysis of Mycobacterium ulcerans [J].J Clin Microbiol，2000，38(4):1482～1487.
14 Hockmeyer W T, Krieg R E, Reich M，et al. Further characterization of Mycobacterium ulcerans toxin [J].Infect Immun, 1978,21(1):124～128.
15 George K M,Pascopella L,Welty D M,et al. A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells [j].Infect Immun,2000,68(2)：877～883.
16 Mve-Obiang A, Lee R E,Portaels F,et al.Heterogeneity of myco-lactones produced by clinical isolates of Mycobacterium ulcerans：implications for virulence [J].Infect Immun, 2003,71(2):774～783.
17 Gooding T M，Johnson P D，Smith M，et ai. Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected house-hold contacts [J].Infect Immun,2002,70( 10):5562～5567.
18 Van der Werf TS, Stienstra Y, Van der Graaf W T. Skin ulcers misdiagnosed as pyoderma gangrenosum [J].N Engl J Med,2003,348(11):1064～1066.
19 Espey D K, Djomand G, Diomande I,et al. A pilot study of treat-ment of Buruli ulcer with rifampin and dapsone [J].Int J Infect Dis,2002,6(l):6019Espey D K, Djomand G, Diomande I, et al. A pilot study of treat-ment of Buruli ulcer with rifampin and dapsone [J]. Int J Infect Dis,2002,6(l):60～65.
20 Dhople A M, Namba K. Activities of sitafloxacin (DU-6859a), either singly or in combination with rifampin,against Mycobacterium ulcerans infection in mice [J]. J Chemother,2003，15(1):47～52.
21 Dega H，Bentoucha A, Robert J，et al. Bactericidal activity of ri-fampin-amikacin against Mycobacterium ulcerans in mice [J]. Anti-microb Agents Chemother,2002,46(10):3193～3196.
22 Krieg R E, Wolcott J H, Meyers W M. Mycobacterium ulcerans in-fection:treatment with rifampin, hyperbaric oxygenation, and heat ther singly or in combination with rifampin,against Mycobacterium ulcerans infection in mice [J].J Chemother,2003，15( 1) :47～52.